Impact of CD34+ cell dose on the outcome of blood allogeneic transplantations in patients with haematological malignancy

被引:0
|
作者
Vadikolia, C [1 ]
Sakellari, I [1 ]
Smias, C [1 ]
Yannaki, E [1 ]
Dourvas, G [1 ]
Tachynopoulou, V [1 ]
Kartsios, H [1 ]
Batsis, L [1 ]
Marantidou, M [1 ]
Fassas, A [1 ]
Anagnostopoulos, A [1 ]
Papanicolaou, G [1 ]
机构
[1] Hosp, Thessaloniki, Greece
关键词
D O I
暂无
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
引用
收藏
页码:S122 / S122
页数:1
相关论文
共 50 条
  • [1] Impact of a Low CD34+ Cell Dose on Allogeneic Peripheral Blood Stem Cell Transplantation
    Yamamoto, Chihiro
    Ogawa, Hiroyasu
    Fukuda, Takahiro
    Igarashi, Aiko
    Okumura, Hirokazu
    Uchida, Naoyuki
    Hidaka, Michihiro
    Nakamae, Hirohisa
    Matsuoka, Ken-Ichi
    Eto, Tetsuya
    Ichinohe, Tatsuo
    Atsuta, Yoshiko
    Kanda, Yoshinobu
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (04) : 708 - 716
  • [2] The impact of the CD34+ cell dose on engraftment in allogeneic peripheral blood stem cell transplantation
    Ilhan, O
    Arslan, Ö
    Arat, M
    Beksaç, M
    Akan, H
    Özcan, M
    Gürman, G
    Konuk, N
    Uysal, A
    Koç, H
    [J]. TRANSFUSION SCIENCE, 1999, 20 (01): : 69 - 71
  • [3] Impact of CD34+ cell dose on the outcome of patients undergoing reduced-intensity-conditioning allogeneic peripheral blood stem cell transplantation
    Pérez-Simón, JA
    Díez-Campelo, M
    Martino, R
    Sureda, A
    Caballero, D
    Cañizo, C
    Brunet, S
    Altes, A
    Vazquez, L
    Sierra, J
    San Miguel, JF
    [J]. BLOOD, 2003, 102 (03) : 1108 - 1113
  • [4] Impact of CD34+ cell dose on the outcome of patients undergoing non-myeloablative allogeneic peripheral blood stem cell transplantation (PBSCT).
    Diez-Campelo, M
    Perez-Simon, JA
    Martino, R
    Canals, C
    Caballero, D
    Mateos, V
    Sierra, J
    San Miguel, JF
    [J]. BLOOD, 2002, 100 (11) : 837A - 837A
  • [5] Experience with 100 HLA-identical, allogeneic blood stem cell transplantations: CD34+ cell dose and engraftment.
    Korbling, M
    Mirza, N
    Thall, P
    Huh, Y
    Fischer, H
    Fahmy, H
    Przepiorka, D
    Anderlini, P
    Mehra, R
    Claxton, D
    Andersson, B
    vanBesien, K
    Khouri, I
    Gajewski, J
    Giralt, S
    Champlin, R
    [J]. BLOOD, 1996, 88 (10) : 2451 - 2451
  • [6] Impact of CD34+ Stem Cell Dose on Engraftment Period in Allogeneic Peripheral Blood Stem Cell Transplanted Patients
    Suria, A. A.
    Diyana, Hazlina B.
    Zakari, Zed A. H.
    Nurasyikin, Y.
    Yousuf, R.
    Azma, R. Z.
    [J]. MEDICINE AND HEALTH, 2021, 16 (01): : 39 - 49
  • [7] Impact of transplanted CD34+ cell dose in allogeneic unmanipulated peripheral blood stem cell transplantation
    S K Sohn
    J G Kim
    D H Kim
    N Y Lee
    J S Suh
    K B Lee
    [J]. Bone Marrow Transplantation, 2003, 31 : 967 - 972
  • [8] Allogeneic transplantation of CD34+ selected cells from peripheral blood for acute myeloid leukemia in first remission:: impact of CD34+ cell dose and total body irradiation in the clinical outcome
    Canals, C
    Urbano-Ispizua, A
    de la Rubia, J
    Odriozola, J
    Tormo, M
    Bueno, J
    Parody, R
    Bargay, J
    Diez, J
    Jurado, M
    Forés, R
    Brunet, S
    Rovira, M
    Esteve, J
    Sanz, M
    Sierra, J
    [J]. BONE MARROW TRANSPLANTATION, 2003, 31 : S170 - S171
  • [9] CD34+ Cell Dose in Allogeneic Transplantation: Weight Considerations
    Lisa Basquiera, Ana
    Abichain, Patricia
    Carlos Damonte, Juan
    Jose Garcia, Juan
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (01) : 196 - 196
  • [10] Controlling T cell dose in CD34+ allogeneic transplant
    Loudovaris, M
    Unverzagt, K
    Yacob, D
    Jaramillo, J
    Bender, J
    Deans, R
    [J]. BONE MARROW TRANSPLANTATION, 1998, 21 : S100 - S100